Should I buy Gentherm Incorporated (THRM) stock or is it too late?
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
Firm-by-firm track record on Gentherm Incorporated
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| JP Morgan | 69 % | +10.0 % | 13 | $48 +19% |
✅ Reasons to believe
- The most reliable firm on THRM, JP Morgan (69% hit rate, 13 scored calls), targets $48 (call made on July 24, 2026, maturing on July 24, 2027) (+19%) in its most recent call, and $43 (call made on October 20, 2025, maturing on October 20, 2026) (+6%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 5 ratings, 3 are neutral.
- Limited upside: the median target is only -1% from the current price.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on THRM
Median target $40 (-1%) · 5 ratings · Hold consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Gentherm Incorporated now?
We won't decide for you. The facts: 40% of analysts rate it a buy, median target $40 (-1%), and JP Morgan (most reliable on THRM, 69%) targets $48. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in Gentherm Incorporated?
The stated upside is small: the median target ($40) sits just -1% from the price ($40) (most reliable on THRM: JP Morgan, 69%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Gentherm Incorporated still worth investing in?
It depends on the gap between the price ($40) and its estimated value: analysts target $40 on median (-1%), with 40% buys (most reliable on THRM: JP Morgan, 69%). Cross-check with their real reliability on THRM and the cautions above. Information, not advice.
What's the main risk in buying THRM?
The consensus is not unanimous: of 5 ratings, 3 are neutral.
→ Go deeper: the full Gentherm Incorporated profile (consensus, analyst reliability, price target, performance).